{"altmetric_id":16116868,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":24},"twitter":{"unique_users_count":15,"unique_users":["psych2evidence","Ezzoef","FlorinDanPopesc","laurivdp","mariana_vieru","winder_gill","NPAGNetwork","DrLoriConnors","adrianastefan6","mssoppyboots","UrticariaCronic","sergiobarbaecua","Savicarmen","FloricaAPopescu","eczemasupport"],"posts_count":20},"facebook":{"unique_users_count":3,"unique_users":["620726827951148","468846129966464","490570534304779"],"posts_count":3},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"selected_quotes":["H1-antihistamine-refractory chronic #urticaria: worse than thought -first results of AWARE study [Maurer et al,2017] h\u2026","H1-antihistamine-refractory chronic #urticaria: real-life AWARE study [Maurer et al, 2017] #W\u2026","H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought","H1-antihistamine-refractory chronic #urticaria: real-life AWARE study [Maurer et al, 2017] #WAW17 @worldallergy","H1-antihistamine-refractory chronic #urticaria: worse than thought -first results of AWARE study [Maurer et al,2017]"],"citation":{"abstract":"Most data on chronic spontaneous urticaria (CSU) originate from highly selected patient populations treated at specialized centers. Little is known about CSU patient characteristics and the burden of CSU in routine clinical practice. AWARE (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation) is an ongoing global study designed to assess chronic urticaria in the real-life setting.\nTo describe the baseline characteristics of the first 1,539 German AWARE patients with H1-antihistamine-refractory CSU.\nThis prospective non-interventional study included patients (18 to 75 years) with a diagnosis of H1-antihistamine-refractory CSU for >2 months. Baseline demographic and disease characteristics, comorbidities, and pharmacological treatments were recorded. Quality of life (QoL) was assessed using the dermatology life quality index (DLQI), chronic urticaria QoL questionnaire (CU-Q2 oL), and angioedema QoL questionnaire (AE-QoL; in cases of angioedema). Previous healthcare resource utilization and sick leave data were collected retrospectively.\nBetween March and December 2014, 1,539 patients were assessed in 256 sites across Germany. The percentage of females, mean age, and mean body mass index was 70%, 46.3 years, and 27 kg\/m(2) , respectively. The mean UCT score was 7.9, 1 in 2 patients had angioedema, and the most frequent comorbidities were chronic inducible urticaria (CIndU; 24%), allergic rhinitis (18.2%), hypertension (18.1%), asthma (12%), and depression (9.5%). Overall, 57.6% of patients were receiving at least one pharmacological treatment including second generation H1-antihistamines (46.3%), first generation H1-antihistamines (9.1%), and corticosteroids (15.8%). The mean DLQI, total CU-Q2 oL, and total AE-QoL scores were 8.3, 36.2, and 46.8, respectively. CSU patients reported frequent use of healthcare resources, including emergency services (29.7%), general practitioners (71.9%), and additional allergists or dermatologists (50.7%).\nThis study reveals that German H1-antihistamine-refractory CSU patients have high rates of uncontrolled disease, angioedema, and comorbid CIndU, are undertreated, have impaired QoL, and rely heavily on healthcare resources. This article is protected by copyright. All rights reserved.","altmetric_jid":"4f6fa4ea3cf058f610002545","authors":["Maurer, Marcus","Staubach, Petra","Raap, Ulrike","Richter\u2010Huhn, Grit","Bauer, Andrea","Ru\u00ebff, Franziska","Jakob, Thilo","Yazdi, Amir S.","Mahler, Vera","Wagner, Nicola","Lippert, Undine","Hillen, Uwe","Schwinn, Andreas","Pawlak, Mario","Behnke, Norbert","Chaouche, Kamel","Chapman\u2010Rothe, Nadine"],"doi":"10.1111\/cea.12900","first_seen_on":"2017-02-04T09:29:28+00:00","funders":["niehs"],"issns":["0954-7894","1365-2222","09547894"],"journal":"Clinical & Experimental Allergy","last_mentioned_on":1493360749,"links":["http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12900\/abstract;jsessionid=7B9FF83B7A506F5B89A0232BF067F274.f01t02","http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12900\/full","http:\/\/dx.doi.org\/10.1111\/cea.12900"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12900\/pdf","pmid":"28160338","pubdate":"2017-02-01T00:00:00+00:00","publisher":"Wiley-Blackwell","publisher_subjects":[{"name":"Immunology","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Immunology and Microbiology"],"subjects":["allergyandimmunology"],"title":"H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/h1antihistaminerefractory-chronic-spontaneous-urticaria-worse-we-thought-first-results-multicenter-r"},"altmetric_score":{"score":10.05,"score_history":{"1y":10.05,"6m":4.25,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":10.05},"context_for_score":{"all":{"total_number_of_other_articles":8215057,"mean":6.9559604438422,"rank":829953,"this_scored_higher_than_pct":89,"this_scored_higher_than":7383997,"rank_type":"exact","sample_size":8215057,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":265304,"mean":12.777378182681,"rank":42428,"this_scored_higher_than_pct":83,"this_scored_higher_than":222798,"rank_type":"exact","sample_size":265304,"percentile":83},"this_journal":{"total_number_of_other_articles":1720,"mean":5.6099965095986,"rank":157,"this_scored_higher_than_pct":90,"this_scored_higher_than":1562,"rank_type":"exact","sample_size":1720,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":35,"mean":8.8402941176471,"rank":6,"this_scored_higher_than_pct":82,"this_scored_higher_than":29,"rank_type":"exact","sample_size":35,"percentile":82}}},"demographics":{"poster_types":{"member_of_the_public":10,"researcher":3,"practitioner":2},"users":{"twitter":{"cohorts":{"Members of the public":10,"Scientists":3,"Practitioners (doctors, other healthcare professionals)":2}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":1,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":4}}},"geo":{"twitter":{"GB":5,"RO":4,"CA":1,"ES":1,"EC":1},"mendeley":{"PT":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/727271699","license":"public","citation_ids":[16116868],"posted_on":"2017-02-17T00:00:00+00:00","f1000_classes":["confirmation"],"f1000_score":"1"}],"twitter":[{"url":"http:\/\/twitter.com\/psych2evidence\/statuses\/827811234544226304","license":"gnip","citation_ids":[16116868],"posted_on":"2017-02-04T09:29:12+00:00","author":{"name":"Psych2 Evidence","image":"https:\/\/pbs.twimg.com\/profile_images\/590651515787993088\/48DTFkEi_normal.jpg","description":"Real-time Evidence-Based Psychiatry Online #ebm #digital #technology #evidence #psychiatry #mentalhealth #futuremedicine Dr Naik @UniofOxford EBHC Student","id_on_source":"psych2evidence","tweeter_id":"3192717557","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":964},"tweet_id":"827811234544226304"},{"url":"http:\/\/twitter.com\/Ezzoef\/statuses\/829000180422832129","license":"gnip","citation_ids":[16116868],"posted_on":"2017-02-07T16:13:39+00:00","author":{"name":"Esther van Zuuren","image":"https:\/\/pbs.twimg.com\/profile_images\/2673561307\/8c1e7934f0a802d9d9f3fba5f6090aa3_normal.jpeg","description":"Dermatologist, systematic reviewer Cochrane Collaboration, free spirit, music lover, fond of Dru yoga, travelling, books, the good things in life.","id_on_source":"Ezzoef","tweeter_id":"858280129","geo":{"lt":null,"ln":null},"followers":530},"tweet_id":"829000180422832129"},{"url":"http:\/\/twitter.com\/FlorinDanPopesc\/statuses\/830091565288808448","license":"gnip","citation_ids":[16116868],"posted_on":"2017-02-10T16:30:26+00:00","author":{"name":"Florin-Dan Popescu","url":"https:\/\/florindanpopescu.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/889896022666878977\/mlK6rhcQ_normal.jpg","description":"Allergist, Assoc. Professor,\nNational Rep @EAACI_HQ,\n#TeamFollowBack 4 #ContinuousAllergyAwareness, Tweets\/RTweets\u2260medical advice, Following\/RTweets\u2260endorsement","id_on_source":"FlorinDanPopesc","tweeter_id":"1423225123","geo":{"lt":null,"ln":null},"followers":5643},"tweet_id":"830091565288808448"},{"url":"http:\/\/twitter.com\/laurivdp\/statuses\/830095928342245381","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T16:47:46+00:00","author":{"name":"DrLauri van der Poel","image":"https:\/\/pbs.twimg.com\/profile_images\/902760447035805696\/9XCerbuF_normal.jpg","description":"Paediatric Allergist, #NHS #EAACI paed section board. #foodallergy #CUrticaria #innovation #meded #digihealth #medtech #foodmaestro #qualitycare #QOL @chtrust1","id_on_source":"laurivdp","tweeter_id":"1915782007","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1338},"tweet_id":"830095928342245381"},{"url":"http:\/\/twitter.com\/mariana_vieru\/statuses\/830098732343508993","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T16:58:54+00:00","author":{"name":"Mariana Vieru","image":"https:\/\/pbs.twimg.com\/profile_images\/902202696073084932\/BS_OERDK_normal.jpg","description":"Associate Professor, #allergy and clinical #immunology","id_on_source":"mariana_vieru","tweeter_id":"4255623796","geo":{"lt":44.43225,"ln":26.10626,"country":"RO"},"followers":102},"tweet_id":"830098732343508993"},{"url":"http:\/\/twitter.com\/FlorinDanPopesc\/statuses\/830101424340099072","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T17:09:36+00:00","author":{"name":"Florin-Dan Popescu","url":"https:\/\/florindanpopescu.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/889896022666878977\/mlK6rhcQ_normal.jpg","description":"Allergist, Assoc. Professor,\nNational Rep @EAACI_HQ,\n#TeamFollowBack 4 #ContinuousAllergyAwareness, Tweets\/RTweets\u2260medical advice, Following\/RTweets\u2260endorsement","id_on_source":"FlorinDanPopesc","tweeter_id":"1423225123","geo":{"lt":null,"ln":null},"followers":5643},"tweet_id":"830101424340099072"},{"url":"http:\/\/twitter.com\/FlorinDanPopesc\/statuses\/830105987822583809","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T17:27:44+00:00","author":{"name":"Florin-Dan Popescu","url":"https:\/\/florindanpopescu.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/889896022666878977\/mlK6rhcQ_normal.jpg","description":"Allergist, Assoc. Professor,\nNational Rep @EAACI_HQ,\n#TeamFollowBack 4 #ContinuousAllergyAwareness, Tweets\/RTweets\u2260medical advice, Following\/RTweets\u2260endorsement","id_on_source":"FlorinDanPopesc","tweeter_id":"1423225123","geo":{"lt":null,"ln":null},"followers":5643},"tweet_id":"830105987822583809"},{"url":"http:\/\/twitter.com\/winder_gill\/statuses\/830117892649795584","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T18:15:03+00:00","author":{"name":"Dr. Winder Gill","image":"https:\/\/pbs.twimg.com\/profile_images\/530765692904439808\/pFAMESLW_normal.jpeg","description":"Western University; Division of Clinical Immunology & Allergy; Lifelong learner, inspired by those around me! Views are my own.","id_on_source":"winder_gill","tweeter_id":"2875332224","geo":{"lt":43.25011,"ln":-79.84963,"country":"CA"},"followers":439},"tweet_id":"830117892649795584"},{"url":"http:\/\/twitter.com\/NPAGNetwork\/statuses\/830131109891551232","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T19:07:34+00:00","author":{"name":"ChildrensallergyNE","image":"https:\/\/pbs.twimg.com\/profile_images\/604343669186019328\/ltlkFqKN_normal.jpg","description":"Northern Paediatric Allergy Group Education and research in paediatric allergy North East, Cumbria, Northumbria, UK - Twitter since 2013.","id_on_source":"NPAGNetwork","tweeter_id":"2432588556","geo":{"lt":54.97328,"ln":-1.61396,"country":"GB"},"followers":521},"tweet_id":"830131109891551232"},{"url":"http:\/\/twitter.com\/DrLoriConnors\/statuses\/830148234584682496","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-10T20:15:37+00:00","author":{"name":"Lori Connors","image":"https:\/\/pbs.twimg.com\/profile_images\/655119967742898176\/RlbRiB-5_normal.jpg","description":"Allergist, Immunologist, mom of two, med ed enthusiast. Tweets are my own views, not medical advice.","id_on_source":"DrLoriConnors","tweeter_id":"2843647437","geo":{"lt":null,"ln":null},"followers":224},"tweet_id":"830148234584682496"},{"url":"http:\/\/twitter.com\/adrianastefan6\/statuses\/830434897470877696","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-11T15:14:42+00:00","author":{"name":"adriana stefan","image":"https:\/\/pbs.twimg.com\/profile_images\/730823766243213312\/Y7prMPqC_normal.jpg","description":"Allergist, MD","id_on_source":"adrianastefan6","tweeter_id":"714811497344536576","geo":{"lt":46,"ln":25,"country":"RO"},"followers":37},"tweet_id":"830434897470877696"},{"url":"http:\/\/twitter.com\/mssoppyboots\/statuses\/830809180332253185","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-02-12T16:01:58+00:00","author":{"name":"Ms TLB","image":"https:\/\/pbs.twimg.com\/profile_images\/882213164569559040\/CbgoI-yr_normal.jpg","description":"A Chronic Autoimmune Urticaria, Angioedema and Rosacea sufferer who is currently in remission. I survived 5 months of Ciclosporin (just!)\nProud Middlesexian!","id_on_source":"mssoppyboots","tweeter_id":"171501158","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":186},"tweet_id":"830809180332253185"},{"url":"http:\/\/twitter.com\/UrticariaCronic\/statuses\/831176985560891392","license":"gnip","citation_ids":[16116868],"posted_on":"2017-02-13T16:23:30+00:00","author":{"name":"Urticaria Cr\u00f3nica","url":"http:\/\/urticariacronica.org","image":"https:\/\/pbs.twimg.com\/profile_images\/470886915286118400\/p4BfIa-D_normal.png","description":"Asociaci\u00f3n de Afectados de Urticaria Cr\u00f3nica (AAUC). Cuenta oficial de la asociaci\u00f3n sin \u00e1nimo de lucro que agrupa a los afectados d urticaria cr\u00f3nica en Espa\u00f1a","id_on_source":"UrticariaCronic","tweeter_id":"2522282425","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":879},"tweet_id":"831176985560891392"},{"url":"http:\/\/twitter.com\/sergiobarbaecua\/statuses\/834846697507414017","license":"gnip","citation_ids":[16116868],"posted_on":"2017-02-23T19:25:38+00:00","author":{"name":"Sergio Barba","url":"http:\/\/www.aaaalergia.com","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"sergiobarbaecua","tweeter_id":"188846475","geo":{"lt":-0.22985,"ln":-78.52495,"country":"EC"},"followers":65},"tweet_id":"834846697507414017"},{"url":"http:\/\/twitter.com\/FlorinDanPopesc\/statuses\/848945029137780736","license":"gnip","citation_ids":[16116868],"posted_on":"2017-04-03T17:07:22+00:00","author":{"name":"Florin-Dan Popescu","url":"https:\/\/florindanpopescu.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/889896022666878977\/mlK6rhcQ_normal.jpg","description":"Allergist, Assoc. Professor,\nNational Rep @EAACI_HQ,\n#TeamFollowBack 4 #ContinuousAllergyAwareness, Tweets\/RTweets\u2260medical advice, Following\/RTweets\u2260endorsement","id_on_source":"FlorinDanPopesc","tweeter_id":"1423225123","geo":{"lt":null,"ln":null},"followers":5643},"tweet_id":"848945029137780736"},{"url":"http:\/\/twitter.com\/mariana_vieru\/statuses\/848949765639467008","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-04-03T17:26:11+00:00","author":{"name":"Mariana Vieru","image":"https:\/\/pbs.twimg.com\/profile_images\/902202696073084932\/BS_OERDK_normal.jpg","description":"Associate Professor, #allergy and clinical #immunology","id_on_source":"mariana_vieru","tweeter_id":"4255623796","geo":{"lt":44.43225,"ln":26.10626,"country":"RO"},"followers":102},"tweet_id":"848949765639467008"},{"url":"http:\/\/twitter.com\/Savicarmen\/statuses\/848950920197140481","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-04-03T17:30:46+00:00","author":{"name":"Carmen Saviana Ganea","image":"https:\/\/pbs.twimg.com\/profile_images\/547330693416488960\/vIHKKR5v_normal.png","description":"Allergy Specialist MD #allergist","id_on_source":"Savicarmen","tweeter_id":"306967692","geo":{"lt":44.43225,"ln":26.10626,"country":"RO"},"followers":24},"tweet_id":"848950920197140481"},{"url":"http:\/\/twitter.com\/FloricaAPopescu\/statuses\/848998379489292290","license":"gnip","rt":["FlorinDanPopesc"],"citation_ids":[16116868],"posted_on":"2017-04-03T20:39:21+00:00","author":{"name":"Florentina Popescu","image":"https:\/\/pbs.twimg.com\/profile_images\/679015162490277889\/Fj5mguTT_normal.jpg","description":"Professor of #Pharmacology","id_on_source":"FloricaAPopescu","tweeter_id":"4277532736","geo":{"lt":44.31667,"ln":23.8,"country":"RO"},"followers":41},"tweet_id":"848998379489292290"},{"url":"http:\/\/twitter.com\/Ezzoef\/statuses\/857826733235556352","license":"gnip","citation_ids":[16116868],"posted_on":"2017-04-28T05:20:05+00:00","author":{"name":"Esther van Zuuren","image":"https:\/\/pbs.twimg.com\/profile_images\/2673561307\/8c1e7934f0a802d9d9f3fba5f6090aa3_normal.jpeg","description":"Dermatologist, systematic reviewer Cochrane Collaboration, free spirit, music lover, fond of Dru yoga, travelling, books, the good things in life.","id_on_source":"Ezzoef","tweeter_id":"858280129","geo":{"lt":null,"ln":null},"followers":530},"tweet_id":"857826733235556352"},{"url":"http:\/\/twitter.com\/eczemasupport\/statuses\/857843275478294528","license":"gnip","rt":["Ezzoef"],"citation_ids":[16116868],"posted_on":"2017-04-28T06:25:49+00:00","author":{"name":"Nottingham Eczema","url":"http:\/\/www.nottinghameczema.org.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/522162557\/N_normal.jpg","description":"Supporting carers of children with eczema","id_on_source":"eczemasupport","tweeter_id":"21676274","geo":{"lt":52.9536,"ln":-1.15047,"country":"GB"},"followers":6265},"tweet_id":"857843275478294528"}],"facebook":[{"title":"H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study. - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1423107704379719&id=620726827951148","license":"public","citation_ids":[16116868,16116868],"posted_on":"2017-02-07T17:16:50+00:00","summary":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28160338","author":{"name":"Instituto de Alergia Campinas","url":"https:\/\/www.facebook.com\/620726827951148","facebook_wall_name":"Instituto de Alergia Campinas","image":"https:\/\/graph.facebook.com\/620726827951148\/picture","id_on_source":"620726827951148"}},{"title":"H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study. - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=615867265264349&id=468846129966464","license":"public","citation_ids":[16116868,16116868],"posted_on":"2017-02-07T17:17:12+00:00","summary":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28160338","author":{"name":"Grupo de Estudos Brasileiro em Angioedema Heredit\u00e1rio - Gebraeh","url":"https:\/\/www.facebook.com\/468846129966464","facebook_wall_name":"Grupo de Estudos Brasileiro em Angioedema Heredit\u00e1rio - Gebraeh","image":"https:\/\/graph.facebook.com\/468846129966464\/picture","id_on_source":"468846129966464"}},{"title":"H1-antihistamine-refractory chronic spontaneous urticaria: It's worse than we thought - first results of the multicenter real-life AWARE study. - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1593465224015299&id=490570534304779","license":"public","citation_ids":[16116868,16116868],"posted_on":"2017-02-23T19:25:35+00:00","summary":"CONCLUSION & CLINICAL RELEVANCE:\nThis study reveals that German H1-antihistamine-refractory CSU patients have high rates of uncontrolled disease, angioedema, and comorbid CIndU, are undertreated, have impaired QoL, and rely heavily on healthcare resources.","author":{"name":"Sociedad Ecuatoriana De Alergia,asma E Inmunologia (SEAAI)","url":"https:\/\/www.facebook.com\/490570534304779","facebook_wall_name":"Sociedad Ecuatoriana De Alergia,asma E Inmunologia (SEAAI)","image":"https:\/\/graph.facebook.com\/490570534304779\/picture","id_on_source":"490570534304779"}}]}}